Provided by Tiger Trade Technology Pte. Ltd.

Chemed

540.27
-0.3050-0.06%
Volume:56.23K
Turnover:30.46M
Market Cap:7.03B
PE:27.18
High:545.00
Open:542.32
Low:539.51
Close:540.57
52wk High:557.00
52wk Low:365.21
Shares:13.02M
Float Shares:11.85M
Volume Ratio:0.54
T/O Rate:0.47%
Dividend:2.40
Dividend Rate:0.44%
EPS(TTM):19.88
EPS(LYR):18.34
ROE:27.11%
ROA:13.45%
PB:8.47
PE(LYR):29.46

Loading ...

Chemed CEO Kevin McNamara sells 2,000 shares worth $842,260

Reuters
·
May 05

Chemed' VITAS Continues to Build Momentum, RBC Says

MT Newswires Live
·
Apr 28

Chemed Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Apr 27

RBC Lifts Price Target on Chemed to $436 From $422, Keeps Sector Perform Rating

MT Newswires Live
·
Apr 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Apr 27

U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global

Reuters
·
Apr 27

Chemed Corp : RBC Raises Target Price to $436 From $422

THOMSON REUTERS
·
Apr 27

Chemed Earnings Call: VITAS Shines, Roto-Rooter Strains

TIPRANKS
·
Apr 25

Sensient Technologies, Chemed, AMD, Arm And Other Big Stocks Moving Higher On Friday

Benzinga
·
Apr 24

Stock Track | Chemed Soars 6.02% in Post-Market Trading on Strong Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track
·
Apr 24

Chemed Shares Gain on Full-Year Outlook

Dow Jones
·
Apr 24

Chemed Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 24

Chemed Q1 revenue rises 1.6% to $657.5 million; diluted EPS slips to $4.84

Reuters
·
Apr 24

Stock Track | Chemed Soars 7.96% in After-Hours Trading on Strong Q1 Earnings Beat and Raised Guidance

Stock Track
·
Apr 24

Chemed reports Q1 adjusted EPS $5.65, consensus $5.30

TIPRANKS
·
Apr 24

Chemed Q1 revenue and adjusted EPS beat estimates, raises full-year outlook

Reuters
·
Apr 24

Chemed Q1 Adj. EPS $5.65 Beats $5.30 Estimate, Sales $657.513M Beat $649.819M Estimate

Benzinga Earnings
·
Apr 24

BRIEF-Chemed Q1 Adjusted EPS USD 5.65 Vs. IBES Estimate USD 5.3

Reuters
·
Apr 24

Chemed Corp - Raises 2026 Revenue Growth Ex-Medicare Cap to 6.5%-7.5%

THOMSON REUTERS
·
Apr 24

Chemed Corp FY2026 Shr View $23.88, REV View $2.67 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Apr 24